APTOSE BIOSCIENCES INC's ticker is and the CUSIP is 03835T200. A total of 25 filers reported holding APTOSE BIOSCIENCES INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $13,473 | -77.5% | 21,051 | -79.6% | 0.00% | – |
Q4 2022 | $59,939 | +299.6% | 103,343 | +316.7% | 0.00% | – |
Q3 2022 | $15,000 | -74.6% | 24,800 | -69.0% | 0.00% | – |
Q2 2022 | $59,000 | -35.9% | 80,073 | +17.7% | 0.00% | – |
Q1 2022 | $92,000 | -67.0% | 68,017 | -67.1% | 0.00% | – |
Q4 2021 | $279,000 | -61.3% | 206,776 | -37.5% | 0.00% | – |
Q3 2021 | $721,000 | -2.6% | 331,086 | +48.6% | 0.00% | – |
Q2 2021 | $740,000 | -39.1% | 222,809 | +9.4% | 0.00% | – |
Q1 2021 | $1,216,000 | +24.6% | 203,595 | -8.7% | 0.00% | – |
Q4 2020 | $976,000 | -89.8% | 222,939 | -86.0% | 0.00% | -100.0% |
Q3 2020 | $9,563,000 | +538.0% | 1,593,783 | +570.5% | 0.00% | – |
Q2 2020 | $1,499,000 | -45.8% | 237,697 | -49.0% | 0.00% | -100.0% |
Q1 2020 | $2,766,000 | +2078.0% | 465,663 | +1978.9% | 0.00% | – |
Q4 2019 | $127,000 | +323.3% | 22,400 | +56.8% | 0.00% | – |
Q3 2019 | $30,000 | -73.2% | 14,284 | -74.5% | 0.00% | – |
Q1 2019 | $112,000 | +220.0% | 56,042 | +204.1% | 0.00% | – |
Q4 2018 | $35,000 | -72.0% | 18,427 | -61.8% | 0.00% | – |
Q3 2018 | $125,000 | – | 48,239 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
P.A.W. CAPITAL CORP | 565,000 | $768,000 | 0.80% |
SANDERS MORRIS HARRIS LLC | 2,342,694 | $3,186,000 | 0.62% |
Nantahala Capital Management | 7,322,189 | $9,958,000 | 0.44% |
DRW Securities, LLC | 8,892,437 | $12,094,000 | 0.33% |
PRECEPT MANAGEMENT LLC | 227,000 | $309,000 | 0.33% |
Voss Capital, LLC | 550,000 | $748,000 | 0.24% |
CARLSON CAPITAL L P | 1,564,700 | $2,128,000 | 0.15% |
Annandale Capital, LLC | 200,000 | $272,000 | 0.11% |
Sigma Planning Corp | 791,274 | $1,076,000 | 0.03% |
WealthShield Partners, LLC | 104,920 | $143,000 | 0.02% |